Member Info for Baznick

Lionel, frustrating to all concerned,

Happy with today’s RNS now that DN is on the board. The plus points I take from the past few months, the increased investment from major shareholders, can’t see them chucking money away, so although a risk, my take is it must be way way less than the past.

Also Gino & Russ purchased £50k each in last raise.

So here’s to good news soon.

Cheers Lionel, never watched the video

Lionel ref, Well the email worked , but not our test .

I’ve read the article a couple of times, am I missing something, can’t see ref to which test but took it to be ours?

Bfd spot on, The silver lining is that the AI appears so long that nobody will read it. I don’t know what I’m missing!

Cheers Lionel, FREE always draws a crowd!

Much appreciated theeeeduke

Lionel, is there any reason you know of why that would be their choice?

Also Garonne it works out cost effective! Lets not forget that also.

It’s much more acceptable than bad news!

Sound move by them Sharequest, thank you.

Headline in the article sums it up, surely this will be realised sooner rather than later. What’s not to like.

Exactly nissang, so ref your post at Today 18:26 your not holding yourself to the same criteria, otherwise you could sell up now to avoid being stuck here.

Nissang easier said. So why are you waiting for 2.36p what is magical about that figure.

Most lth’s hopefully have averaged down! but would still like to see some form of reward for their patience.

GLA

Happy today, but still quite a way to go.

Still trying to fathom out, why the surge!

Https://www.londonstockexchange.com/news-article/GDR/sussex-nhs-trust-transitions-mt-rnr1-test-to-bau/17575623

Lionel,

Closing statement

genedrive’s experience demonstrates that the UK has less of a discovery problem, more a deployment problem. Proven, NICE-recommended technologies are already improving patient outcomes within the NHS, yet lack a clear pathway to national adoption. Addressing this gap would:

Improve patient outcomes

Reduce system pressure

Strengthen the UK life sciences sector

The priority should be to ensure that innovations developed in the UK can be routinely adopted within the NHS, at pace and at scale

Garonne, as EC thumps home on a regular basis!

This should be a no brainer, sooner the better.

Nissang I appreciate you would like to be free of this company at 2.36p but to achieve this, we still need sales!

I personally think you will be offered this chance sooner rather than later.

Another thing. It was only a few months ago it was .25p so you could also say it will never get to 1p yet here we are.

Newbie, I’ve been here long enough and lost enough in the past to know how much this can move when we didn’t have any sales let alone once the RNS’s start dropping.

The 1p opportunity won’t remain forever, those that wish to grab the bargain price will be rewarded the most once sales start increasing.

Yes my opinion, only time will tell.

GLA